-
31 July, 2025
barnaclínic+ adds closed-loop systems to its type 1 diabetes treatment offering
The Endocrinology and Nutrition Unit at barnaclínic+ is now offering the most advanced automated insulin delivery systems on the market, providing people with type 1 diabetes better glycemic control, greater autonomy, and improved quality of life.
Treatment for type 1 diabetes has significantly evolved in recent years thanks to new technological developments. Among these, closed-loop systems, also known as artificial pancreas systems, represent a paradigm shift: they automatically adjust insulin delivery based on real-time glucose levels, reducing hypoglycemia and consistently increasing time in range. Most importantly, these improvements are achieved while reducing the patient’s involvement in daily decision-making. At barnaclínic+, this next-generation technology is now available as part of our comprehensive, personalized approach to diabetes treatment.
-
30 June, 2025
barnaclínic+ 2024 Annual Report: sustained growth, new services and a commitment to the future
barnaclínic+ has recently published its 2024 Annual Report, a document that summarises the activity, indicators and initiatives that marked a key year in the institution’s strategic development. Following an intense 2024, focused on care reorganisation, internationalisation and a commitment to reinvesting in the Clínic, 2025 is emerging as a year of continuity and consolidation of the path already set in motion.
